Drug manufacturer Sanofi, in its latest filing in federal district court in New Jersey, called the new 340B administrative resolution system a false judicial process designed to punish drug companies.

Sanofi Calls 340B ADR System “a Faux Judicial Process”

Drug manufacturer Sanofi on Monday struck back at the U.S. Justice Department (DOJ) for opposing its Feb. 2 motion in a federal lawsuit requesting an injunction against the 340B program’s new administrative dispute resolution (ADR) process.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.